Scrip
US FDA prepares for biosimilars in 2011 budget plan, despite stalled reform bill
08 February 2010
Nancy Faigen
As part of the unveiling of the Obama administration's fiscal year 2011 budget,
FDA officials outlined how the agency plans to prepare for an approval pathway for follow-on biologics (or biosimilars), despite a lag in Congress moving to establish an explicit approval process. In total, the FDA seeks...
Please Login to read the full article.
08 February 2010
Nancy Faigen
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
